Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
16.9M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
1.62M
-
Shares change
-
+1.62M
-
Total reported value, excl. options
-
$1.15M
-
Value change
-
+$1.15M
-
Number of buys
-
26
-
Price
-
$0.71
Significant Holders of Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) as of Q1 2023
26 filings reported holding MRKR - Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2023.
Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.62M shares
of 16.9M outstanding shares and own 9.63% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (1.07M shares), VANGUARD GROUP INC (167K shares), Long Focus Capital Management, LLC (146K shares), GEODE CAPITAL MANAGEMENT, LLC (57.8K shares), MILLENNIUM MANAGEMENT LLC (30.8K shares), MATRIX ASSET ADVISORS INC/NY (25K shares), RENAISSANCE TECHNOLOGIES LLC (19.4K shares), STATE STREET CORP (18.7K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (17.6K shares), and Creative Planning (17.6K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.